<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathogenic Escherichia coli associated with diarrhea</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathogenic Escherichia coli associated with diarrhea</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathogenic Escherichia coli associated with diarrhea</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James P Nataro, MD, PhD, MBA</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 02, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Escherichia coli</em> are normal inhabitants of the human gastrointestinal tract and are among the bacterial species most frequently isolated from stool cultures. When <em>E. coli</em> strains acquire certain additional genetic material, they can become pathogenic; these pathogenic clones circulate widely and are among the most virulent enteric pathogens. Diarrheagenic <em>E. coli</em> are among the most frequent bacterial causes of gastroenteritis worldwide. </p><p>The most common diarrheagenic clones can be assigned to specific pathotypes, which have distinct pathogenic, epidemiologic, and clinical characteristics  (<a class="graphic graphic_table graphicRef67152" href="/d/graphic/67152.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. The characteristics of diarrheal illness caused by the following pathotypes will be reviewed here: </p><p class="bulletIndent1"><span class="glyph">●</span>Enterotoxigenic <em>E. coli</em> (ETEC) </p><p class="bulletIndent1"><span class="glyph">●</span>Enteropathogenic <em>E. coli</em> (EPEC)</p><p class="bulletIndent1"><span class="glyph">●</span>Enteroinvasive <em>E. coli</em> (EIEC)</p><p class="bulletIndent1"><span class="glyph">●</span>Enteroaggregative <em>E. coli</em> (EAEC)</p><p></p><p>Shiga toxin-producing <em>E. coli</em> (STEC) is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/2711.html" rel="external">"Shiga toxin-producing Escherichia coli: Microbiology, pathogenesis, epidemiology, and prevention"</a> and  <a class="medical medical_review" href="/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment"</a>.)</p><p class="headingAnchor" id="H3627408738"><span class="h1">COMMON CLINICAL CONCEPTS</span></p><p class="headingAnchor" id="H2"><span class="h2">Microbiology</span><span class="headingEndMark"> — </span><em>E. coli</em> can be cultured readily from the stool under aerobic conditions. On selective media, such as MacConkey agar, <em>E. coli</em> usually appear as dark pink colonies, indicating that the organism ferments lactose  (<a class="graphic graphic_picture graphicRef63042" href="/d/graphic/63042.html" rel="external">picture 1</a>). Additional biochemical identification should also be performed, since up to 10 percent of <em>E. coli</em> do not ferment lactose or ferment lactose relatively slowly. The most useful biochemical identification test for <em>E. coli</em> is the indole test, which is positive in up to 99 percent of <em>E. coli</em> strains.</p><p>Pathogenic <em>E. coli</em> are not distinguishable from other strains or from each other by the appearance on culture plates or by the results of the usual biochemical tests. To determine whether the isolated strain is one of the pathogenic clones or merely a nonpathogenic constituent of the intestinal microbiota, one must employ additional identification techniques; such tests are increasingly available in diagnostic laboratories. (See <a class="local">'Clinical diagnosis'</a> below.)</p><p>Enterohemorrhagic <em>E. coli</em> (EHEC) O157:H7 is the only pathogenic strain that can be identified readily in the clinical laboratory using nonmolecular tests [<a href="#rid2">2</a>]. Such testing can include determining the serotype of the strain and biochemical characteristics demonstrable on agar plates. </p><p>The virulence traits are distinct for each category of pathogenic <em>E. coli</em> [<a href="#rid3">3</a>]. These virulence traits include adherence factors that allow <em>E. coli</em> to attach to the intestinal mucosa, and toxins that interrupt normal intestinal cell secretion and absorption (secretory toxins) or that damage the intestinal cell (cytotoxins). These adherence factors and toxins are encoded on accessory genetic elements in <em>E. coli</em>, such as plasmids, transposons, and bacteriophages.</p><p class="headingAnchor" id="H1293176580"><span class="h2">Clinical diagnosis</span><span class="headingEndMark"> — </span>Identification of one of these pathogenic <em>E. coli</em> isolates through molecular testing on stool in a patient with diarrhea is generally sufficient to make the clinical diagnosis of an <em>E. coli</em> infection. However, a high degree of clinical correlation is necessary, and some caveats are warranted. </p><p>Prior to the increasing availability of commercial molecular tests for diagnosis of diarrheal pathogens, <em>E. coli </em>pathotypes (apart from EHEC O157:H7) were not readily identifiable in the clinical setting, as they are indistinguishable from each other and nonpathogenic <em>E. coli</em> on culture and biochemical testing. (See <a class="local">'Microbiology'</a> above.)</p><p>In the clinical context of stool molecular testing, the relevant gene targets are identified relatively frequently among patients with diarrhea. Given the mosaic nature of the <em>E. coli</em> genome, any of these gene targets may detected in isolation; detection of a single gene target is not equivalent to detection of a pathogen. Moreover, test results may reflect the presence of nonviable organisms or a clinically insignificant pathogen burden [<a href="#rid4">4</a>]. </p><p>For these reasons, we interpret stool molecular test results together with the corresponding clinical context: </p><p class="bulletIndent1"><span class="glyph">●</span>For stool testing demonstrating enteropathogenic <em>E. coli</em> (EPEC; specifically presence of the <em>eae</em> gene in isolation), the clinical context should consist of diarrhea in the absence of a more likely etiology. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For stool testing demonstrating genes with heat-labile or heat-stable enterotoxins, the clinical context should consist of travel to areas with endemic enterotoxigenic <em>E. coli</em> (ETEC). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For stool testing demonstrating a gene-encoding Shiga toxin, this may be presumed to represent Shiga toxin-producing <em>E. coli</em> (STEC) infection, given the epidemiologic and clinical risk associated with this pathogen. Details regarding diagnosis of EHEC are discussed separately. (See  <a class="medical medical_review" href="/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Microbiologic diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H467169135"><span class="h2">Approach to treatment</span><span class="headingEndMark"> — </span>Supportive care with fluid, electrolyte, and nutritional management is the cornerstone of treatment of diarrheal illnesses. (See  <a class="medical medical_review" href="/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings", section on 'Management'</a> and  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings", section on 'Management'</a>.)</p><p>For patients with diarrhea who have a pathogenic <em>E. coli</em> identified on stool testing, we suggest <strong>not</strong> routinely administering antibiotic therapy. Antibiotics can be effective in reducing the duration of diarrhea associated with pathogenic <em>E. coli</em>. However, most cases of diarrhea associated with <em>E. coli</em> resolve spontaneously and antibiotic therapy is associated with selection of resistant organisms and other adverse effects. Additionally, antibiotic therapy is <strong>not</strong> recommended in cases of Shiga toxin-producing <em>E. coli</em> infection because of the association with hemolytic uremic syndrome. (See  <a class="medical medical_review" href="/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Antibiotics'</a>.)</p><p>Antibiotic therapy is reasonable in patients with diarrhea associated with pathogenic <em>E. coli</em> infection (other than STEC such as <em>E. coli</em> O157:H7) that is severe (eg, with fever, more than six stools per day, volume depletion warranting hospitalization) or bloody. Antibiotic therapy is also reasonable in patients with prolonged (&gt;7 days) diarrhea, particularly if no other pathogen has been identified. A lower threshold for antibiotic therapy is appropriate in patients who are at risk for more severe or persistent infection, such as immunocompromised patients. </p><p>When antibiotic therapy is indicated, <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a> or a fluoroquinolone is generally an appropriate choice. For infectious diarrhea, azithromycin is given as a single 1 g dose (for patients without dysentery) or as 500 mg once daily for three days. Appropriate fluoroquinolones include <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> (a single 750 mg dose or 500 mg twice daily for three to five days) and <a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">levofloxacin</a> (500 mg as a single dose or given once daily for three to five days). Studies evaluating the efficacy of antibiotics for particular <em>E. coli</em> pathotypes are limited. Azithromycin and fluoroquinolones have been effective for ETEC in trials of travelers' diarrhea [<a href="#rid5">5,6</a>]. Similarly, several small trials have demonstrated that diarrhea resolved faster when EAEC was cleared from the stool with ciprofloxacin [<a href="#rid7">7,8</a>]. </p><p>Antibiotic resistance among ETEC and EAEC is common. However, since these pathotypes are identified primarily with culture-independent techniques, having a pathogen on hand for susceptibility testing to inform optimal antibiotic selection is unusual. </p><p>Our treatment approach is consistent with the Infectious Diseases Society of America clinical practice guidelines on infectious diarrhea [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3"><span class="h1">ENTEROTOXIGENIC E. COLI</span></p><p class="headingAnchor" id="H1722709541"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span>Enterotoxigenic <em>E. coli</em> (ETEC) causes watery diarrhea in young humans and other mammals in resource-limited settings, as well as in older individuals who have not previously been exposed to the organism [<a href="#rid10">10</a>]. </p><p>Approximately 10<sup>8</sup> to 10<sup>10</sup> ETEC must be ingested to induce diarrhea in an otherwise healthy individual [<a href="#rid1">1</a>]; exposure to this large an inoculum occurs commonly in resource-limited settings since the pathogen thrives in food and water supplies in the absence of adequate sanitation. ETEC is one of the most common bacterial causes of dehydrating diarrheal illness in children under two years of age in these regions [<a href="#rid11">11,12</a>]. These strains can also cause diarrhea in travelers to tropical regions who are exposed to contaminated food and water. In addition, ETEC is emerging as a significant diarrheal pathogen in some resource-rich regions [<a href="#rid13">13-15</a>]. (See  <a class="medical medical_review" href="/d/html/2709.html" rel="external">"Travelers' diarrhea: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>The pathogenesis of disease due to ETEC consists of ingestion of bacteria, intestinal colonization, and elaboration of virulence factor(s). </p><p>ETEC must express colonizing fimbriae (CFs) to permit the attachment of the bacteria to the intestine. Antibodies to fimbrial adhesins, specifically colonization factor antigen I, have been shown to be protective in a mouse model [<a href="#rid16">16</a>].</p><p>Upon colonization, ETEC elaborates one or both of two major classes of plasmid-encoded secretory toxins: heat-labile toxin (LT) and heat-stable toxin (ST) [<a href="#rid17">17</a>]. Only <em>E. coli</em> that contain one or both of these toxin classes are classified as ETEC [<a href="#rid18">18</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>LT is a complex family of toxins related to <em>Vibrio cholerae</em> cholera toxin with respect to structure, function, and mechanism. LT acts by stimulating adenylate cyclase and increasing intracellular cyclic adenosine monophosphate (AMP), which induces secretion of chloride from intestinal crypt cells and inhibition of absorption of sodium chloride at the villus tips. Secretion of free water into the intestinal lumen follows, manifesting clinically as watery diarrhea [<a href="#rid19">19</a>]. Studies suggest that LT and its secretion apparatus can cluster at one end of the bacterial organism, which may permit ETEC to focus toxin delivery to the host intestinal cell [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/141337.html" rel="external">"Cholera: Treatment and prevention", section on 'Introduction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There are two major STs that may be present in ETEC; only one of these, STa, is associated with human disease. STa may exist as a human allele (designated "h") or a porcine allele ("p"). Epidemiologic data are inconclusive with regard to the relative pathogenicity of these alleles. Both STa alleles activate enterocyte cyclic GMP, which leads to the stimulation of chloride secretion and inhibition of sodium chloride absorption. The end result is secretion of free water into the intestinal lumen, which manifests clinically as watery diarrhea [<a href="#rid19">19</a>].</p><p></p><p class="headingAnchor" id="H1517120757"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>ETEC infection has a short incubation period (one to three days), and the onset of symptoms and signs is rapid. Diarrhea is watery and may be mild or severe. Patients may report nausea, but vomiting is relatively uncommon. The illness is self-limiting, lasting one to five days. (See  <a class="medical medical_review" href="/d/html/2709.html" rel="external">"Travelers' diarrhea: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Molecular diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of ETEC is made by molecular detection of the genes for LT or ST [<a href="#rid21">21,22</a>]. Polymerase chain reaction (PCR) or molecular panels that identify ETEC are available in many clinical laboratories.</p><p>Classically, these organisms had previously been identified by bioassays for the secretory toxins: the rabbit ileal loop for LT and the suckling mouse assay for ST, but these research tests have been replaced by molecular testing in many clinical laboratories.</p><p class="headingAnchor" id="H9"><span class="h1">ENTEROPATHOGENIC E. COLI</span><span class="headingEndMark"> — </span>Enteropathogenic <em>E. coli</em> (EPEC) strains are defined by the characteristic "attaching and effacing" effect they elicit upon interaction with epithelial cells and by the fact that they do not produce Shiga toxin  (<a class="graphic graphic_figure graphicRef56217" href="/d/graphic/56217.html" rel="external">figure 1</a>). </p><p class="headingAnchor" id="H3340253227"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span>Typical and atypical EPEC strains have been distinguished based on the presence of certain virulence factors (see <a class="local">'Pathogenesis'</a> below). Typical EPEC (tEPEC) has been associated with severe sporadic diarrheal illness and diarrhea outbreaks, most commonly among children less than six months of age (and almost exclusively in children &lt;2 years of age) in resource-limited countries [<a href="#rid23">23,24</a>]. Atypical EPEC (aEPEC) are less well understood; limited epidemiologic studies suggest that aEPEC may occur at all ages and in resource-rich countries. Nevertheless, evidence suggests that some aEPEC are diarrheal pathogens [<a href="#rid25">25</a>]. (See <a class="local">'Approach to treatment'</a> above.)</p><p class="headingAnchor" id="H11"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>Typical EPEC (tEPEC) harbor a virulence plasmid (pEAF) that encodes the bundle-forming pilus (BFP), the factor required for colonization. In addition, tEPEC carry the Locus for Enterocyte Effacement (LEE) chromosomal island, which contains the <em>eae</em> gene, which encodes an outer membrane protein colonization factor called intimin. To be designated tEPEC, an <em>E. coli</em> strain must possess both pEAF and the <em>eae</em> gene; isolates that have only <em>eae</em> are considered atypical EPEC (aEPEC). </p><p>The site of EPEC infection is thought to be the small intestine. The steps in pathogenesis of tEPEC for initiation of diarrheal illness include [<a href="#rid26">26-29</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Initial localized adherence of the organisms to the enterocyte via the BFP</p><p class="bulletIndent1"><span class="glyph">●</span>Induction of signal transduction in the enterocyte by protein toxin secretion</p><p class="bulletIndent1"><span class="glyph">●</span>Development of intimin-mediated intimate adherence to the enterocyte </p><p></p><p>As above, both tEPEC and aEPEC express the LEE chromosomal island, which elaborates, in addition to intimin, a set of &gt;20 protein toxins that are injected directly into the target epithelial cell. Injection of protein toxins is effected by a complex nanomachine called a type III secretion injectisome [<a href="#rid30">30,31</a>]. The type III "effector" toxins are thought to act by binding to protein elements of the cell's signal transduction apparatus, resulting in a complex series of events that transform a normally absorptive epithelial cell into a secretory dynamo [<a href="#rid32">32</a>]. This is accompanied by mobilization of intracellular calcium, activation of protein kinase C and the myosin-light-chain kinase, and induction of tyrosine phosphorylation of proteins [<a href="#rid33">33</a>]. The effectors induce rearrangement of cytoskeletal proteins, resulting in the classic "attaching and effacing" lesion, alterations in water and electrolyte secretion, and increased permeability of intestinal tight junctions.</p><p>EspF is an LEE-secreted protein that is not involved with attaching and effacing; it appears to disrupt intestinal barrier function by increasing monolayer permeability via alteration of electrical resistance [<a href="#rid34">34</a>]. EspF has several protein-protein interaction domains that may function by interacting with endocytic regulation [<a href="#rid35">35</a>]. Two other secreted proteins, EspG and EspG2, inhibit luminal membrane chloride absorption by decreasing surface expression of the Cl-/OH-exchanger via disruption of microtubules [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H2765955295"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>The diarrhea associated with tEPEC in children can be severe, with concomitant vomiting and dehydration. Stools are typically watery without blood or pus. Fever may occur in a minority of patients. Diarrhea due to aEPEC is also watery and not as severe as that caused by tEPEC.</p><p>If diarrhea persists, malnutrition can be a devastating complication, particularly in resource-limited settings, where resources for supportive therapy may be limited. Micronutrient malnutrition in severe infection may also be a result of direct mechanisms, as suggested by cell culture data demonstrating that EPEC infection inhibits intestinal absorption of thiamine [<a href="#rid37">37</a>]. </p><p class="headingAnchor" id="H12"><span class="h2">Molecular diagnosis</span><span class="headingEndMark"> — </span>The gold standard for identification of tEPEC is the molecular detection by panel or polymerase chain reaction (PCR). Such tests identify either the pEAF plasmid or its encoded bundle-forming pilus (BFP); these tests produce equivalent results. BFP is not found in strains lacking the LEE chromosomal island (tEPEC is defined by the presence of both the pEAF/BFP and the LEE). </p><p>In contrast, tests that target the LEE (via detection of the <em>eae</em> gene, which encodes intimin) can identify isolates that lack the pEAF (by definition, aEPEC). While aEPEC strains have been implicated in diarrhea outbreaks [<a href="#rid25">25</a>], it is likely that not all strains harboring only the <em>eae</em> gene are human pathogens. Thus, treatment of potential aEPEC infections should only be considered in the absence of another pathogen.</p><p class="headingAnchor" id="H15"><span class="h1">ENTEROINVASIVE E. COLI</span><span class="headingEndMark"> — </span>Enteroinvasive <em>E. coli</em> (EIEC) is closely related to <em>Shigella</em> and causes colitis that is similar to shigellosis. Clinical EIEC infection appears to be uncommon, although it may be underdiagnosed. Clinical disease with EIEC begins as watery diarrhea and may or may not proceed to bloody diarrhea and frank dysentery. Infection can result in severe disease. In a rare outbreak of EIEC infection in the United States that involved 52 individuals who had attended a potluck party, 28 (54 percent) were hospitalized and 13 (25 percent) had sepsis [<a href="#rid38">38</a>]. Among the subset interviewed about their symptoms, median onset was 20.5 hours after exposure, 77 percent had watery diarrhea, 54 percent had mucoid diarrhea, and 91 percent had fever.</p><p>The organisms can be detected using nucleic acid tests, including multiplex panels. EIEC invades the intestinal cell, multiplies intracellularly, and extends into the adjacent intestinal cells. The same genes facilitate pathogenesis of both EIEC and <em>Shigella</em> [<a href="#rid39">39</a>]. EIEC may be differentiated from <em>Shigella</em> principally by the fact that EIEC strains ferment glucose and xylose. (See  <a class="medical medical_review" href="/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">ENTEROAGGREGATIVE E. COLI</span><span class="headingEndMark"> — </span>Enteroaggregative <em>E. coli</em> (EAEC) was first described in the 1980s, when collections of <em>E. coli</em> from studies of patients with diarrhea in resource-limited settings were examined in tissue culture adherence assays [<a href="#rid40">40</a>]. <em>E. coli</em> that had a distinctive palisading adherence on human epithelial type 2 (HEp-2) cells were observed more frequently in the stools of children with diarrhea than in children without diarrhea [<a href="#rid41">41</a>]. </p><p class="headingAnchor" id="H328100945"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span>EAEC appears to be a cause of acute and chronic diarrheal illness among many different subpopulations in both resource-limited and resource-rich regions. </p><p>Surveys of <em>E. coli</em> from diarrhea outbreaks in Europe have demonstrated the presence of EAEC in both outbreaks and sporadic cases of diarrhea [<a href="#rid42">42,43</a>]. In a prospective study of patients presenting with diarrhea to two large medical centers in the United States, EAEC was observed in 4.5 percent of cases and was identified more frequently among cases than asymptomatic controls [<a href="#rid44">44</a>]. One meta-analysis noted a positive correlation between acute diarrheal illness and EAEC excretion (diagnosed by aggregative adherence assay) in the following groups [<a href="#rid45">45</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Children residing in both resource-limited and resource-rich regions</p><p class="bulletIndent1"><span class="glyph">●</span>Adults with and without human immunodeficiency virus (HIV) infection residing in resource-limited regions</p><p class="bulletIndent1"><span class="glyph">●</span>International travelers to resource-limited regions</p><p></p><p>EAEC has also been repeatedly associated with persistent diarrhea among children studied from Chile, Brazil, Mexico, India, and Bangladesh [<a href="#rid46">46-52</a>], and has been associated with persistent diarrhea among adults with HIV infection, particularly those with advanced immune suppression, in the United States and Switzerland [<a href="#rid53">53,54</a>]. </p><p>As with many diarrheal pathogens, not all studies have identified a link between EAEC and clinically significant diarrhea [<a href="#rid12">12,55</a>]. We consider treatment of patients shedding EAEC in the setting of clinically significant diarrhea in the absence of another likely pathogen.  </p><p>In a large multi-center, case-control study among children younger than five years of age in sub-Saharan Africa or south Asia, EAEC was extremely common among both children with diarrhea and controls and was not epidemiologically associated with moderate-to-severe diarrhea [<a href="#rid12">12</a>]. However, a multi-center longitudinal study of children in resource-limited countries suggested that asymptomatic carriage of EAEC could predict linear growth retardation [<a href="#rid56">56</a>]. This association has been previously reported in individual studies [<a href="#rid57">57</a>] and suggests that the burden of EAEC disease may more closely parallel asymptomatic carriage than watery diarrhea. </p><p class="headingAnchor" id="H18"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>The pathogenesis of diarrhea caused by EAEC is incompletely elucidated [<a href="#rid41">41</a>]. EAEC are capable of inducing the release of interleukin (IL)-8 from polarized colonic T84 cells [<a href="#rid58">58</a>] and inducing epithelial barrier dysfunction [<a href="#rid59">59</a>].</p><p>Most EAEC strains harbor a transcriptional activator called AggR [<a href="#rid60">60</a>]; AggR activates a large number of genes that are likely involved in pathogenesis. EAEC strains that possess AggR and its regulon are termed typical EAEC strains. Given that most epidemiologic studies addressing EAEC detect the organism by virtue of AggR-dependent genes, most of what is known about EAEC involves typical strains. </p><p>A variety of EAEC pathogenetic mechanisms have been postulated:</p><p class="bulletIndent1"><span class="glyph">●</span>Adherence fimbriae (variants AAF/1<strong>-</strong>AAF/V) are present in nearly all typical EAEC strains, and the AAF-encoding genes are directly controlled by AggR itself [<a href="#rid61">61</a>]. AAF-encoding genes are carried on a virulence plasmid (pAA) in typical EAEC; pAA also encodes AggR. An AggR-activated and pAA-encoded protein called dispersin (encoded by the <em>aap</em> gene) appears to promote AAF-mediated colonization [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mucosal destruction has been demonstrated in clinical specimens and in tissue culture assays, and a protease cytotoxin has been identified in many EAEC strains [<a href="#rid63">63</a>]. Serine family proteases are commonly found in EAEC and may be associated with diarrheagenic strains [<a href="#rid64">64</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some EAEC strains may invade tissue culture cells and induce IL-8 production via mitogen-activated protein kinase [<a href="#rid65">65,66</a>].</p><p></p><p class="headingAnchor" id="H2411330615"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>As above, both acute and chronic diarrhea have been associated with EAEC. Patients with symptomatic infection typically present with watery diarrhea without blood in the stools. In one study that included 37 patients with EAEC-associated diarrhea, concomitant fever, abdominal pain, and vomiting were reported in 43, 65, and 57 percent, respectively [<a href="#rid44">44</a>]. </p><p>In 2011, a typical EAEC strain that had become lysogenized with a Shiga toxin-encoding phage was associated with a large multi-country outbreak of hemorrhagic colitis and hemolytic uremic syndrome (HUS) [<a href="#rid67">67</a>]. This outbreak, responsible for 52 deaths, was linked to contaminated fenugreek sprouts. The implicated strain has not been isolated since the outbreak, although other Shiga toxin-producing EAEC have been isolated. Whether these clones will emerge epidemiologically remains to be seen.</p><p class="headingAnchor" id="H19"><span class="h2">Molecular diagnosis</span><span class="headingEndMark"> — </span>The gold standard for the diagnosis of EAEC is detection of the AggR regulon using molecular techniques. Commonly available molecular panels detect EAEC this way. Although no single deoxyribonucleic acid (DNA) target has been epidemiologically linked to pathogenicity, the linkage of the AggR regulon with pathogenesis suggests that targeting any number of AggR-activated genes for detection will produce similar diagnostic performance. </p><p>Other methods for identifying EAEC include detection of aggregative adherence to HEp-2 cells in culture; EAEC has a distinctive palisading adherence pattern. While not used in clinical laboratories, research studies have used this technique for diagnosing cases [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H489297799"><span class="h1">SHIGA TOXIN-PRODUCING AND ENTEROHEMORRHAGIC E. COLI</span><span class="headingEndMark"> — </span>Some strains of <em>E. coli</em> produce Shiga toxin. Shiga toxin-producing strains that also demonstrate an "attaching and effacing" lesion like enteropathogenic <em>E. coli</em> (albeit in the colon, not the small intestine) are categorized as enterohemorrhagic <em>E. coli</em> (EHEC). A particularly virulent subset of EHEC organisms belongs to serotype O157:H7 [<a href="#rid2">2,68</a>]; non-O157 serotypes also account for a large proportion of EHEC infections  (<a class="graphic graphic_figure graphicRef56217" href="/d/graphic/56217.html" rel="external">figure 1</a>).</p><p>EHEC strains, especially those belonging to serotype O157:H7, have been responsible for large outbreaks of bloody diarrhea, some associated with hemolytic uremic syndrome, a triad of microangiopathic anemia, renal failure, and thrombocytopenia [<a href="#rid69">69,70</a>]. </p><p>Shiga toxin-producing <em>E. coli</em> infection is discussed further elsewhere. (See  <a class="medical medical_review" href="/d/html/2711.html" rel="external">"Shiga toxin-producing Escherichia coli: Microbiology, pathogenesis, epidemiology, and prevention"</a> and  <a class="medical medical_review" href="/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment"</a>.)</p><p>Shiga toxin-associated hemolytic uremic syndrome is discussed further separately. (See  <a class="medical medical_review" href="/d/html/6081.html" rel="external">"Clinical manifestations and diagnosis of Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome in children"</a> and  <a class="medical medical_review" href="/d/html/6097.html" rel="external">"Treatment and prognosis of Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome in children"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">OTHER E. COLI STRAINS</span><span class="headingEndMark"> — </span>There are no good data supporting the association of other types of <em>E. coli</em> (eg, diffusely adherent <em>E. coli</em>, detaching <em>E. coli</em>) with diarrhea. However, since <em>E. coli</em> are ubiquitous and have a demonstrated capacity for acquiring the DNA for virulence traits from other organisms, additional groups of <em>E. coli</em> will probably be associated with diarrheal disease in the future.</p><p class="headingAnchor" id="H1655258809"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109942.html" rel="external">"Society guideline links: Acute diarrhea in adults"</a>.)</p><p class="headingAnchor" id="H19898838"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/83761.html" rel="external">"Patient education: Travelers' diarrhea (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/86006.html" rel="external">"Patient education: E. coli diarrhea (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2830629"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenic </strong><strong><em>Escherichia coli</em></strong> – <em>E. coli</em> are normal inhabitants of the human gastrointestinal tract. When <em>E. coli</em> strains acquire certain additional genetic material, they can become pathogenic. <em>E. coli</em> are among the most frequent bacterial causes of diarrhea. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Features</strong> – The different <em>E. coli</em> pathotypes have distinct epidemiologic, clinical, and pathogenic features  (<a class="graphic graphic_table graphicRef67152" href="/d/graphic/67152.html" rel="external">table 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Enterotoxigenic </strong><strong><em>E. coli</em></strong><strong> (ETEC)</strong> – ETEC survives readily in water and food and is one of the most common bacterial causes of dehydrating diarrheal illness in children under two years of age in resource-limited regions. ETEC can also cause diarrhea among travelers to tropical regions and is emerging as a pathogen in resource-rich settings. ETEC causes primarily watery diarrhea through plasmid-encoded toxin production. (See <a class="local">'Enterotoxigenic E. coli'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Enteropathogenic </strong><strong><em>E. coli</em></strong><strong> (EPEC)</strong> – EPEC has been associated with sporadic diarrheal illness and diarrhea outbreaks, most commonly among children under six months of age in resource-limited countries. EPEC strains are defined by their characteristic "attaching and effacing" effect upon interaction with epithelial cells and by the fact that they do not produce Shiga toxin. EPEC proteins affect cell physiology through adherence and induction of signal transduction. (See <a class="local">'Enteropathogenic E. coli'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Enterohemorrhagic </strong><strong><em>E. coli</em></strong><strong> (EHEC)</strong> – EHEC strains are capable of producing Shiga toxin and, like EPEC strains, demonstrate an "attaching and effacing" lesion. EHEC strains, especially those belonging to serotype O157:H7 (and also O104:H4) have been responsible for large outbreaks of bloody diarrhea, some associated with hemolytic uremic syndrome. (See <a class="local">'Shiga toxin-producing and enterohemorrhagic E. coli'</a> above and  <a class="medical medical_review" href="/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Enteroinvasive </strong><strong><em>E. coli</em></strong><strong> (EIEC)</strong> – EIEC infection appears to be uncommon. Clinical disease begins as watery diarrhea that may progress to bloody diarrhea and dysentery. EIEC is closely related to <em>Shigella</em>, and the same genes facilitate pathogenesis of both organisms. EIEC invades the intestinal cell, multiplies intracellularly, and extends into the adjacent intestinal cells. (See <a class="local">'Enteroinvasive E. coli'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Enteroaggregative </strong><strong><em>E. coli</em></strong><strong> (EAEC)</strong> – EAEC is associated with persistent and acute diarrheal illness among many demographic groups in both resource-limited and -rich settings and may be associated with linear growth retardation. On tissue culture adherence assays, EAEC has a distinctive palisading adherence on human epithelial type 2 (HEp-2) cells. The pathogenesis of diarrhea caused by EAEC is incompletely elucidated. (See <a class="local">'Enteroaggregative E. coli'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – <em>E. coli</em> can be cultured readily from the stool under aerobic conditions. However, pathogenic <em>E. coli</em> are not distinguishable from nonpathogenic strains or from each other by their appearance on culture plates or by the results of the usual biochemical tests. <em>E. coli</em> O157:H7 (EHEC) is the only pathogenic strain that can be identified readily without molecular testing. With the increasing availability of commercial molecular tests for diagnosis of diarrheal pathogens, other <em>E. coli </em>pathotypes are being identified more frequently. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical diagnosis</strong> – Identification of one of these pathogenic <em>E. coli</em> isolates through molecular testing on stool is not tantamount to an <em>E. coli</em> infection. Clinical correlation is required, along with consideration of potential alternative etiologies. A positive test in an asymptomatic patient does not indicate infection. (See <a class="local">'Clinical diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management </strong>(See <a class="local">'Approach to treatment'</a> above.)<strong> </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Supportive care</strong> – Supportive care with fluid, electrolytes, and nutritional management is the cornerstone of treatment of diarrheal illnesses. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of antibiotics</strong> </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with diarrhea who have a pathogenic <em>E. coli</em> identified on stool testing, we suggest <strong>not</strong> routinely administering antibiotic therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Antibiotic therapy (eg, with <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a> or <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a>) is reasonable in patients with severe, bloody, or persistent diarrhea, particularly in children or immunocompromised hosts. </p><p></p><p class="headingAnchor" id="H1339503656"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Christine A Wanke, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142.</a></li><li><a class="nounderline abstract_t">March SB, Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 1986; 23:869.</a></li><li><a class="nounderline abstract_t">Cassels FJ, Wolf MK. Colonization factors of diarrheagenic E. coli and their intestinal receptors. J Ind Microbiol 1995; 15:214.</a></li><li><a class="nounderline abstract_t">Binnicker MJ. Multiplex Molecular Panels for Diagnosis of Gastrointestinal Infection:  Performance, Result Interpretation, and Cost-Effectiveness. J Clin Microbiol 2015; 53:3723.</a></li><li><a class="nounderline abstract_t">Mattila L, Peltola H, Siitonen A, et al. Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis 1993; 17:779.</a></li><li><a class="nounderline abstract_t">Sanders JW, Frenck RW, Putnam SD, et al. Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey. Clin Infect Dis 2007; 45:294.</a></li><li><a class="nounderline abstract_t">Glandt M, Adachi JA, Mathewson JJ, et al. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin Infect Dis 1999; 29:335.</a></li><li><a class="nounderline abstract_t">Wanke CA, Gerrior J, Blais V, et al. Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus. J Infect Dis 1998; 178:1369.</a></li><li><a class="nounderline abstract_t">Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 2017; 65:1963.</a></li><li><a class="nounderline abstract_t">Black RE, Merson MH, Rowe B, et al. Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area. Bull World Health Organ 1981; 59:263.</a></li><li><a class="nounderline abstract_t">Black RE, Brown KH, Becker S, et al. Contamination of weaning foods and transmission of enterotoxigenic Escherichia coli diarrhoea in children in rural Bangladesh. Trans R Soc Trop Med Hyg 1982; 76:259.</a></li><li><a class="nounderline abstract_t">Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209.</a></li><li><a class="nounderline abstract_t">Beatty ME, Adcock PM, Smith SW, et al. Epidemic diarrhea due to enterotoxigenic Escherichia coli. Clin Infect Dis 2006; 42:329.</a></li><li><a class="nounderline abstract_t">Devasia RA, Jones TF, Ward J, et al. Endemically acquired foodborne outbreak of enterotoxin-producing Escherichia coli serotype O169:H41. Am J Med 2006; 119:168.e7.</a></li><li><a class="nounderline abstract_t">Yoder JS, Cesario S, Plotkin V, et al. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin Infect Dis 2006; 42:1513.</a></li><li><a class="nounderline abstract_t">Alves AM, Lásaro MO, Pyrrho AS, et al. Antibody response in mice immunized with a plasmid DNA encoding the colonization factor antigen I of enterotoxigenic Escherichia coli. FEMS Immunol Med Microbiol 1999; 23:321.</a></li><li><a class="nounderline abstract_t">Evans DG, Evans DJ Jr, Pierce NF. Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun 1973; 7:873.</a></li><li><a class="nounderline abstract_t">Levine MM, Caplan ES, Waterman D, et al. Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun 1977; 17:78.</a></li><li><a class="nounderline abstract_t">Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 1996; 60:167.</a></li><li><a class="nounderline abstract_t">Dorsey FC, Fischer JF, Fleckenstein JM. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Cell Microbiol 2006; 8:1516.</a></li><li><a class="nounderline abstract_t">Moseley SL, Echeverria P, Seriwatana J, et al. Identification of enterotoxigenic Escherichia coli by colony hybridization using three enterotoxin gene probes. J Infect Dis 1982; 145:863.</a></li><li><a class="nounderline abstract_t">Begaud E, Germani Y. Detection of enterotoxigenic Escherichia coli in faecal specimens by acetylaminofluorene-labelled DNA probes. Res Microbiol 1992; 143:315.</a></li><li><a class="nounderline abstract_t">Rothbaum R, McAdams AJ, Giannella R, Partin JC. A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology 1982; 83:441.</a></li><li><a class="nounderline abstract_t">Bonner KE, Carter M, Zielinski C, et al. Notes from the Field: Enteropathogenic Escherichia coli Outbreak at a Child Care Center - Oregon, August 2021. MMWR Morb Mortal Wkly Rep 2022; 71:527.</a></li><li><a class="nounderline abstract_t">Hedberg CW, Savarino SJ, Besser JM, et al. An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. J Infect Dis 1997; 176:1625.</a></li><li><a class="nounderline abstract_t">Donnenberg MS, Calderwood SB, Donohue-Rolfe A, et al. Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells. Infect Immun 1990; 58:1565.</a></li><li><a class="nounderline abstract_t">Donnenberg MS, Tzipori S, McKee ML, et al. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest 1993; 92:1418.</a></li><li><a class="nounderline abstract_t">Dytoc M, Fedorko L, Sherman PM. Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro. Gastroenterology 1994; 106:1150.</a></li><li><a class="nounderline abstract_t">Finlay BB, Rosenshine I, Donnenberg MS, Kaper JB. Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells. Infect Immun 1992; 60:2541.</a></li><li><a class="nounderline abstract_t">Pinaud L, Sansonetti PJ, Phalipon A. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors. Trends Microbiol 2018; 26:266.</a></li><li><a class="nounderline abstract_t">Gaytán MO, Martínez-Santos VI, Soto E, González-Pedrajo B. Type Three Secretion System in Attaching and Effacing Pathogens. Front Cell Infect Microbiol 2016; 6:129.</a></li><li><a class="nounderline abstract_t">Rabinowitz RP, Lai LC, Jarvis K, et al. Attaching and effacing of host cells by enteropathogenic Escherichia coli in the absence of detectable tyrosine kinase mediated signal transduction. Microb Pathog 1996; 21:157.</a></li><li><a class="nounderline abstract_t">Rosenshine I, Donnenberg MS, Kaper JB, Finlay BB. Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. EMBO J 1992; 11:3551.</a></li><li><a class="nounderline abstract_t">McNamara BP, Koutsouris A, O'Connell CB, et al. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 2001; 107:621.</a></li><li><a class="nounderline abstract_t">Weflen AW, Alto NM, Hecht GA. Tight junctions and enteropathogenic E. coli. Ann N Y Acad Sci 2009; 1165:169.</a></li><li><a class="nounderline abstract_t">Gill RK, Borthakur A, Hodges K, et al. Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. J Clin Invest 2007; 117:428.</a></li><li><a class="nounderline abstract_t">Ashokkumar B, Kumar JS, Hecht GA, Said HM. Enteropathogenic Escherichia coli inhibits intestinal vitamin B1 (thiamin) uptake: studies with human-derived intestinal epithelial Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 2009; 297:G825.</a></li><li><a class="nounderline abstract_t">Herzig CTA, Fleischauer AT, Lackey B, et al. Notes from the Field: Enteroinvasive Escherichia coli Outbreak Associated with a Potluck Party - North Carolina, June-July 2018. MMWR Morb Mortal Wkly Rep 2019; 68:183.</a></li><li><a class="nounderline abstract_t">Tulloch EF Jr, Ryan KJ, Formal SB, Franklin FA. Invasive enteropathic Escherichia coli dysentery. An outbreak in 28 adults. Ann Intern Med 1973; 79:13.</a></li><li><a class="nounderline abstract_t">Nataro JP, Kaper JB, Robins-Browne R, et al. Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J 1987; 6:829.</a></li><li><a class="nounderline abstract_t">Vial PA, Robins-Browne R, Lior H, et al. Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis 1988; 158:70.</a></li><li><a class="nounderline abstract_t">Scotland SM, Smith HR, Cheasty T, et al. Use of gene probes and adhesion tests to characterise Escherichia coli belonging to enteropathogenic serogroups isolated in the United Kingdom. J Med Microbiol 1996; 44:438.</a></li><li><a class="nounderline abstract_t">Cobeljić M, Miljković-Selimović B, Paunović-Todosijević D, et al. Enteroaggregative Escherichia coli associated with an outbreak of diarrhoea in a neonatal nursery ward. Epidemiol Infect 1996; 117:11.</a></li><li><a class="nounderline abstract_t">Nataro JP, Mai V, Johnson J, et al. Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin Infect Dis 2006; 43:402.</a></li><li><a class="nounderline abstract_t">Huang DB, Nataro JP, DuPont HL, et al. Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis 2006; 43:556.</a></li><li><a class="nounderline abstract_t">Bhan MK, Khoshoo V, Sommerfelt H, et al. Enteroaggregative Escherichia coli and Salmonella associated with nondysenteric persistent diarrhea. Pediatr Infect Dis J 1989; 8:499.</a></li><li><a class="nounderline abstract_t">Bhan MK, Raj P, Levine MM, et al. Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis 1989; 159:1061.</a></li><li><a class="nounderline abstract_t">Bhatnagar S, Bhan MK, Sommerfelt H, et al. Enteroaggregative Escherichia coli may be a new pathogen causing acute and persistent diarrhea. Scand J Infect Dis 1993; 25:579.</a></li><li><a class="nounderline abstract_t">Cravioto A, Reyes RE, Ortega R, et al. Prospective study of diarrhoeal disease in a cohort of rural Mexican children: incidence and isolated pathogens during the first two years of life. Epidemiol Infect 1988; 101:123.</a></li><li><a class="nounderline abstract_t">Gunzburg ST, Chang BJ, Elliott SJ, et al. Diffuse and enteroaggregative patterns of adherence of enteric Escherichia coli isolated from aboriginal children from the Kimberley region of Western Australia. J Infect Dis 1993; 167:755.</a></li><li><a class="nounderline abstract_t">Henry FJ, Udoy AS, Wanke CA, Aziz KM. Epidemiology of persistent diarrhea and etiologic agents in Mirzapur, Bangladesh. Acta Paediatr Suppl 1992; 381:27.</a></li><li><a class="nounderline abstract_t">Wanke CA, Schorling JB, Barrett LJ, et al. Potential role of adherence traits of Escherichia coli in persistent diarrhea in an urban Brazilian slum. Pediatr Infect Dis J 1991; 10:746.</a></li><li><a class="nounderline abstract_t">Mayer HB, Wanke CA. Enteroaggregative Escherichia coli as a possible cause of diarrhea in an HIV-infected patient. N Engl J Med 1995; 332:273.</a></li><li><a class="nounderline abstract_t">Wanke CA, Mayer H, Weber R, et al. Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus. J Infect Dis 1998; 178:185.</a></li><li><a class="nounderline abstract_t">Imdad A, Foster MA, Iqbal J, et al. Diarrheagenic Escherichia coli and Acute Gastroenteritis in Children in Davidson County, Tennessee, United States: A Case-control Study. Pediatr Infect Dis J 2018; 37:543.</a></li><li><a class="nounderline abstract_t">Rogawski ET, Guerrant RL, Havt A, et al. Epidemiology of enteroaggregative Escherichia coli infections and associated outcomes in the MAL-ED birth cohort. PLoS Negl Trop Dis 2017; 11:e0005798.</a></li><li><a class="nounderline abstract_t">Rogawski ET, Guerrant RL. The Burden of Enteropathy and "Subclinical" Infections. Pediatr Clin North Am 2017; 64:815.</a></li><li><a class="nounderline abstract_t">Harrington SM, Strauman MC, Abe CM, Nataro JP. Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell Microbiol 2005; 7:1565.</a></li><li><a class="nounderline abstract_t">Strauman MC, Harper JM, Harrington SM, et al. Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions. Infect Immun 2010; 78:4958.</a></li><li><a class="nounderline abstract_t">Nataro JP. Enteroaggregative Escherichia coli pathogenesis. Curr Opin Gastroenterol 2005; 21:4.</a></li><li><a class="nounderline abstract_t">Morin N, Santiago AE, Ernst RK, et al. Characterization of the AggR regulon in enteroaggregative Escherichia coli. Infect Immun 2013; 81:122.</a></li><li><a class="nounderline abstract_t">Sheikh J, Czeczulin JR, Harrington S, et al. A novel dispersin protein in enteroaggregative Escherichia coli. J Clin Invest 2002; 110:1329.</a></li><li><a class="nounderline abstract_t">Navarro-García F, Sears C, Eslava C, et al. Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli. Infect Immun 1999; 67:2184.</a></li><li><a class="nounderline abstract_t">Boisen N, Scheutz F, Rasko DA, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis 2012; 205:431.</a></li><li><a class="nounderline abstract_t">Benjamin P, Federman M, Wanke CA. Characterization of an invasive phenotype associated with enteroaggregative Escherichia coli. Infect Immun 1995; 63:3417.</a></li><li><a class="nounderline abstract_t">Khan K, Konar M, Goyal A, Ghosh S. Enteroaggregative Escherichia coli infection induces IL-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in INT-407 cells. Mol Cell Biochem 2010; 337:17.</a></li><li><a class="nounderline abstract_t">Rasko DA, Webster DR, Sahl JW, et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 2011; 365:709.</a></li><li><a class="nounderline abstract_t">Johnson KE, Thorpe CM, Sears CL. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 2006; 43:1587.</a></li><li><a class="nounderline abstract_t">Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995; 333:364.</a></li><li><a class="nounderline abstract_t">Karmali MA, Petric M, Lim C, et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151:775.</a></li></ol></div><div id="topicVersionRevision">Topic 2720 Version 43.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9457432" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diarrheagenic Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3519658" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8519480" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Colonization factors of diarrheagenic E. coli and their intestinal receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26311866" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Multiplex Molecular Panels for Diagnosis of Gastrointestinal Infection:  Performance, Result Interpretation, and Cost-Effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8268363" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18688944" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10476738" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9780257" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29194529" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7018729" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7048652" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Contamination of weaning foods and transmission of enterotoxigenic Escherichia coli diarrhoea in children in rural Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23680352" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16392076" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Epidemic diarrhea due to enterotoxigenic Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16443428" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Endemically acquired foodborne outbreak of enterotoxin-producing Escherichia coli serotype O169:H41.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16652306" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10225292" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Antibody response in mice immunized with a plasmid DNA encoding the colonization factor antigen I of enterotoxigenic Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4577415" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/328397" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8852900" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16922869" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7045250" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Identification of enterotoxigenic Escherichia coli by colony hybridization using three enterotoxin gene probes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1448616" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Detection of enterotoxigenic Escherichia coli in faecal specimens by acetylaminofluorene-labelled DNA probes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7044882" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35389972" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Notes from the Field: Enteropathogenic Escherichia coli Outbreak at a Child Care Center - Oregon, August 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9395379" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2160428" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8376595" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8174877" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1587620" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29477730" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27818950" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Type Three Secretion System in Attaching and Effacing Pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8878013" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Attaching and effacing of host cells by enteropathogenic Escherichia coli in the absence of detectable tyrosine kinase mediated signal transduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1396556" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11238563" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19538303" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Tight junctions and enteropathogenic E. coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17256057" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19628653" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Enteropathogenic Escherichia coli inhibits intestinal vitamin B1 (thiamin) uptake: studies with human-derived intestinal epithelial Caco-2 cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30789875" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Notes from the Field: Enteroinvasive Escherichia coli Outbreak Associated with a Potluck Party - North Carolina, June-July 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4578638" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Invasive enteropathic Escherichia coli dysentery. An outbreak in 28 adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3313248" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2899125" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8636961" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Use of gene probes and adhesion tests to characterise Escherichia coli belonging to enteropathogenic serogroups isolated in the United Kingdom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8760945" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Enteroaggregative Escherichia coli associated with an outbreak of diarrhoea in a neonatal nursery ward.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16838226" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16886146" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2671906" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Enteroaggregative Escherichia coli and Salmonella associated with nondysenteric persistent diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2656875" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8284642" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Enteroaggregative Escherichia coli may be a new pathogen causing acute and persistent diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3402544" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Prospective study of diarrhoeal disease in a cohort of rural Mexican children: incidence and isolated pathogens during the first two years of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8440943" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Diffuse and enteroaggregative patterns of adherence of enteric Escherichia coli isolated from aboriginal children from the Kimberley region of Western Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1421936" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Epidemiology of persistent diarrhea and etiologic agents in Mirzapur, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1658721" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Potential role of adherence traits of Escherichia coli in persistent diarrhea in an urban Brazilian slum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7808505" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Enteroaggregative Escherichia coli as a possible cause of diarrhea in an HIV-infected patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9652439" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29341983" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Diarrheagenic Escherichia coli and Acute Gastroenteritis in Children in Davidson County, Tennessee, United States: A Case-control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28742106" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Epidemiology of enteroaggregative Escherichia coli infections and associated outcomes in the MAL-ED birth cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28734512" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The Burden of Enteropathy and "Subclinical" Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16207244" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20823198" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15687877" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Enteroaggregative Escherichia coli pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23090962" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Characterization of the AggR regulon in enteroaggregative Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12417572" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A novel dispersin protein in enteroaggregative Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10225873" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22184729" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Genomic characterization of enteroaggregative Escherichia coli from children in Mali.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7642271" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Characterization of an invasive phenotype associated with enteroaggregative Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19898747" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Enteroaggregative Escherichia coli infection induces IL-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in INT-407 cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21793740" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17109294" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7609755" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Escherichia coli O157:H7 and the hemolytic-uremic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3886804" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
